Appili LIKMEZ™ (ATI-1501) Metronidazole Oral Suspension OKd

 FDA approves LIKMEZ as the brand name for Metronidazole Oral Suspension (LIKMEZ is a Trademark of Saptalis Pharmaceuticals, LLC)

Currently LIKMEZ is the only liquid oral suspension of metronidazole approved in the U.S.

Patent coverage provides drug market exclusivity through at least 2039

https://www.biospace.com/article/releases/appili-therapeutics-announces-u-s-fda-approval-of-likmez-ati-1501-metronidazole-oral-suspension/